Rhizopus microsporus pulmonary sepsis: Case report and review of literature


Case Report

Author Details : Umamaheswari K*, Gnanasekar R, Sadagopan Kumar

Volume : 8, Issue : 3, Year : 2022

Article Page : 270-275

https://doi.org/10.18231/j.ijmmtd.2022.053



Suggest article by email

Get Permission

Abstract

Background: The incidence of opportunistic fungal infection, mucormycosis associated with high mortality rate is steadily increasing. Pulmonary mucormycosis though rare, it relatively affects individuals with diabetes mellitus and other immunosuppressive conditions. The present study reports on case of pulmonary mucormycosis caused by Rhizopus microsporus.
Materials and Methods: Sputum sample was collected from a 47-year-old male with diagnosed with tuberculosis with spontaneous left sided pneumothorax and diabetes mellitus. The positive fungal culture was characterized by phenotypic and genotypic methods and antifungal susceptibility of the isolate was tested against azoles and amphotericin B.
Results: The etiological agent was identified as R. microsporus based on phenotypic features and molecular sequencing of ITS. The isolate was susceptible to all the tested antifungal and the patient responded well to Amphotericin B with strict glycemic control and combination of anti-infective therapy.
Conclusion: Though pulmonary mucormycosis is relatively rare; it share its clinical picture with pulmonary tuberculosis and aspergillosis, hence clinical suspicion for mucormycosis in susceptible high risk patients is warranted for early diagnosis and appropriate therapy.
 

Keywords: Pulmonary mucormycosis, Diabetes mellitus, Rhizopus microsporus, Amphotericin B


How to cite : Umamaheswari K, Gnanasekar R, Kumar S, Rhizopus microsporus pulmonary sepsis: Case report and review of literature. IP Int J Med Microbiol Trop Dis 2022;8(3):270-275


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







Article History

Received : 05-05-2022

Accepted : 18-05-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmmtd.2022.053


Article Metrics






Article Access statistics

Viewed: 497

PDF Downloaded: 136



Medical Abbreviation List